Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos Chouaid

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
BMC Pulmonary Medicine|August 8, 2012
Multidimensional analyses to assess the relations between treatment choices by physicians and patients' characteristics: the example of COPDNicolas Roche, Christos Chouaid, Bertrand Delclaux, et al.
BMC Public Health|August 20, 2010
Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004Nadia Valin, Gilles Hejblum, Isabelle Borget, et al.
Translational Lung Cancer Research|February 17, 2025
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case reportJulie Lasvergnas, Isabelle Monnet, Jean-Bernard Auliac, et al.
Targeted Oncology|February 3, 2016
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future TrendsChristos Chouaid, Isabelle Borget, Eric Braun, et al.
Medical & Biological Engineering & Computing|April 15, 2022
Analysis of COVID-19 inpatients in France during first lockdown of 2020 using explainability methodsJean-Baptiste Excoffier, Noémie Salaün-Penquer, Matthieu Ortala, et al.
Respiratory Medicine|August 6, 2016
Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort studyLaurent Laforest, Nicolas Roche, Gilles Devouassoux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in FranceChristos Chouaid, Lionel Bensimon, Emilie Clay, et al.
Plos One|February 22, 2022
Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysisCamille Jung, Jean-Baptiste Excoffier, Mathilde Raphaël-Rousseau, et al.
Journal of Market Access & Health Policy|April 29, 2016
Current process and future path for health economic assessment of pharmaceuticals in FranceMondher Toumi, Cécile Rémuzat, Emna El Hammi, et al.
Cancer Treatment Reviews|August 7, 2024
Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literatureAnne-Laure Désage, Michael Duruisseaux, Claire Lafitte, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
BMC Pulmonary Medicine|August 8, 2012
Multidimensional analyses to assess the relations between treatment choices by physicians and patients' characteristics: the example of COPDNicolas Roche, Christos Chouaid, Bertrand Delclaux, et al.
BMC Public Health|August 20, 2010
Factors associated with excessively lengthy treatment of tuberculosis in the eastern Paris region of France in 2004Nadia Valin, Gilles Hejblum, Isabelle Borget, et al.
Translational Lung Cancer Research|February 17, 2025
Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case reportJulie Lasvergnas, Isabelle Monnet, Jean-Bernard Auliac, et al.
Targeted Oncology|February 3, 2016
French Health Technology Assessment of Antineoplastic Drugs Indicated in the Treatment of Solid Tumours: Perspective for Future TrendsChristos Chouaid, Isabelle Borget, Eric Braun, et al.
Medical & Biological Engineering & Computing|April 15, 2022
Analysis of COVID-19 inpatients in France during first lockdown of 2020 using explainability methodsJean-Baptiste Excoffier, Noémie Salaün-Penquer, Matthieu Ortala, et al.
Respiratory Medicine|August 6, 2016
Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort studyLaurent Laforest, Nicolas Roche, Gilles Devouassoux, et al.
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Cost-effectiveness analysis of pembrolizumab versus standard-of-care chemotherapy for first-line treatment of PD-L1 positive (>50%) metastatic squamous and non-squamous non-small cell lung cancer in FranceChristos Chouaid, Lionel Bensimon, Emilie Clay, et al.
Plos One|February 22, 2022
Evolution of hospitalized patient characteristics through the first three COVID-19 waves in Paris area using machine learning analysisCamille Jung, Jean-Baptiste Excoffier, Mathilde Raphaël-Rousseau, et al.
Journal of Market Access & Health Policy|April 29, 2016
Current process and future path for health economic assessment of pharmaceuticals in FranceMondher Toumi, Cécile Rémuzat, Emna El Hammi, et al.
Cancer Treatment Reviews|August 7, 2024
Toxicities associated with sequential or combined use of immune checkpoint inhibitors and small targeted therapies in non-small cell lung cancer: A critical review of the literatureAnne-Laure Désage, Michael Duruisseaux, Claire Lafitte, et al.
Pageof 21